Characterising the immune infiltrate of B and T cell dominated skin diseases to improve therapeutic options

Recruiting

• Conditions: L63.0; L63.1; L63.2; L63.8; Alopecia (capitis) totalis; Alopecia universalis; Ophiasis; Other alopecia areata

• Registration Number: DRKS00034344
• Lead Sponsor: Medizinische Universität Wien

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-06-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Definite diagnosis of alopecia areata with a defined clinical subtype.

Exclusion Criteria

Pregnancy.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Characterisation of the immune infiltrate in different subtypes of AA and adjacent non-lesional skin.

Secondary Outcome Measures

Name	Time	Method
To identify predictive markers (ie. presence of certain immune cells) that can be used to predict therapy response.